Study: HPV Caused Oral Cancer Near Epidemic in Men; polyDNA Recommends Gene-Eden-VIR Against the Latent HPV

A study published on October 11, 2013 in the medical journal Oral Oncology said that the rising importance of the total number of head and neck cancer (SCCHN) deaths is directly related to the growing number of HPV positive cases (1). polyDNA recommends Gene-Eden-VIR to help the immune system target the latent HPV.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
genital warts remedy
We believe that because HPV vaccines do not help those with an existing HPV infection, these individuals need a remedy like Gene-Eden-VIR, which was proven to reduce HPV symptoms in a recent post-marketing clinical study. – Mike Evans, polyDNA

Rochester, NY (PRWEB) October 19, 2013

Over the last few decades, the rates of head and neck cancers caused by HPV (Squamous Cell Carcinomas of the Head and Neck, or SCCHN) have increased worldwide. Because of this marked increase in SCCHN cancers, researchers from the University of Pittsburgh Medical Center wrote that, “This near epidemic increase heralds an immediate need to develop better therapies to treat this disease (1).”

Surprisingly, the HPV vaccine has only limited effectiveness against these cancers. As study authors wrote, “DNA vaccines for HPV related cancers (such as Gardasil) are attractive for multiple reasons, yet are significantly limited by (many) problems…(1).”

Head and neck cancers caused by HPV have a better prognosis than SCCHNs caused by something other than the HPV virus (such as smoking). However, HPV is responsible for the highest number of SCCHNs cases. Moreover, HPV vaccinations seem to have no impact on this number. Study authors wrote that, “HPV positive oropharyngeal SCC continues to be an emerging epidemic despite preventative vaccines. The prognosis for this subset of head and neck cancers is by comparison excellent with conventional therapy; however, treatment morbidity is significant (1).”

“We believe that because HPV vaccines do not help those with an existing HPV infection, these individuals need a remedy like Gene-Eden-VIR, which was proven to reduce HPV symptoms in a recent post-marketing clinical study.” – Mike Evans, polyDNA

In a study published on August 12, 2013 in the peer reviewed, medical journal Pharmacology & Pharmacy, in a special edition on Advances in Antiviral Drugs, showed that Gene-Eden-VIR reduced HPV symptoms in individuals already infected with HPV. Study authors wrote that, “Individuals infected with the HPV…reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR (2).” The study authors also wrote that, “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms (2).”

To learn more about Gene-Eden-VIR, and HPV visit http://www.gene-eden-kill-virus.com. All orders of Gene-Eden-VIR are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

###

References:

(1)    http://www.ncbi.nlm.nih.gov/pubmed/24126224
(2)    http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.

polyDNA developed Gene-Eden-VIR, an antiviral natural remedy that helps the immune system kill latent viruses.